Weight loss for women in midlife: working with menopause, not against it

What changes after 45

The Study of Women's Health Across the Nation (SWAN) followed women through the menopause transition with body composition scans. Fat mass began rising and lean mass began falling about two years before the final period, and the pace of fat gain nearly doubled during the transition before leveling off afterward. Total weight rose steadily, which hid how much the composition underneath had shifted.

Other things change at the same time. Sleep is often disrupted by night sweats, which affects appetite and energy. Muscle loss lowers daily energy needs. Life in your late 40s and 50s can be busier than ever. None of this means weight loss is impossible; it means the plan has to be built for the body you have now.

What we check first

A comprehensive lab panel is $199, one time. Your clinician decides which tests you need.

• Thyroid function, since an underactive thyroid can cause weight gain and fatigue
• HbA1c and fasting glucose for prediabetes or diabetes
• Lipids, with apoB and Lp(a) where useful, since cholesterol often rises around menopause
• Liver enzymes, which can point to fatty liver
• Iron stores, vitamin D and B12 where relevant
• Your menopause stage, sleep, mood, alcohol and current medicines, some of which cause weight gain

How GLP-1 medicines and hormone therapy fit together

GLP-1 medicines such as semaglutide, and the dual GIP/GLP-1 medicine tirzepatide, reduce appetite and slow stomach emptying. According to the NIDDK, adults using weight-management medicine with lifestyle changes lose on average 3% to 12% more of their starting weight over a year than with lifestyle changes alone, and most people regain some weight after stopping.

Hormone therapy has a different job. The Menopause Society describes it as the most effective treatment for hot flashes and night sweats, with bone protection as an added benefit. It is not approved or recommended for weight loss. But a woman who sleeps through the night again often finds it easier to exercise, plan meals and manage cravings. For many women, a clinician can prescribe both, with monitoring.

Safety: what to know about GLP-1s

The most common side effects are nausea, diarrhea, vomiting, constipation and abdominal pain, usually worst when starting or increasing the dose. Serious but less common risks include pancreatitis, gallbladder problems and kidney injury from dehydration. Branded semaglutide carries a boxed warning about thyroid C-cell tumors seen in rodents; these medicines are not used by anyone with a personal or family history of medullary thyroid carcinoma or MEN2. They are not for use during pregnancy or breastfeeding, and should be stopped before a planned pregnancy.

HealifyMD's semaglutide and tirzepatide are compounded. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are sold. They are not equivalent to or interchangeable with Wegovy or Zepbound, and the clinical trial results for those brands do not automatically apply. If you prefer a branded medication, our membership option supports women using branded GLP-1s.

Protecting muscle and bone while the weight comes off

Fast weight loss can take muscle with it, and women in midlife have less to spare. Bone loss also speeds up around menopause. A good plan protects both.

• Strength training at least two days a week, progressing over time
• Protein at each meal, especially when appetite is low on a GLP-1
• Calcium and vitamin D from food first, with supplements if your clinician suggests them
• A pace of loss your clinician considers safe, adjusted if you feel weak or unwell
• Bone density screening when you are due, done in person

What the first three months look like

After a free eligibility check, you complete labs and a video visit. If a GLP-1 is appropriate, your clinician starts a low dose and increases it gradually to limit side effects. You check in by message, report how you feel and track weight and waist. Around three months, you review progress together and adjust. Per NIDDK, if you have not lost at least 5% of your weight after 12 weeks on a full dose, a clinician will usually recommend a different approach.